Viridian Therapeutics, Inc.
NASDAQ:VRDN
21.06 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -237.734 | -129.874 | -79.413 | -110.715 | -41.873 | -32.703 | -26.512 | -12.674 | -11.328 | -7.89 | -2.16 | -5.618 |
| Depreciation & Amortization
| 0.522 | 0.255 | 0.12 | 0.239 | 0.288 | 0.281 | 0.308 | 0.189 | 0.184 | 0.144 | 0.148 | 0.144 |
| Deferred Income Tax
| 12.04 | 0 | 1.038 | 0.056 | -0.432 | -0.416 | 0 | 0.868 | 0 | 0.177 | 0 | -1.643 |
| Stock Based Compensation
| 67.172 | 19.765 | 14.465 | 3.645 | 3.97 | 3.679 | 2.409 | 2.111 | 3.015 | 4.298 | 0 | 0.008 |
| Change In Working Capital
| -9.425 | 15.962 | 1.724 | 4.427 | 1.651 | 1.939 | -4.466 | 2.182 | 1.099 | 0.105 | -0.649 | -1.608 |
| Accounts Receivables
| 0 | 0.349 | -0.451 | 0.099 | -0.084 | 1.432 | -1.436 | -0.13 | 0.694 | -0.271 | 0.202 | -0.37 |
| Inventory
| 0 | -0.349 | 0.451 | 0 | 0 | -57.795 | -50.9 | 0.123 | -0.008 | 0.178 | -0.187 | 0.166 |
| Accounts Payables
| -12.04 | 11.524 | 1.655 | -0.426 | 0.525 | -0.335 | -0.101 | 2.028 | 0.633 | 0.383 | -0.28 | -1.295 |
| Other Working Capital
| 2.615 | 4.438 | 0.069 | 4.754 | 1.21 | 58.637 | 47.971 | 0.161 | -0.22 | -0.185 | -0.384 | -0.11 |
| Other Non Cash Items
| -16.745 | 0.054 | 7.485 | 72.569 | 0.34 | 0.376 | 0.094 | 0.093 | 0.132 | 0.953 | 1.493 | 2.493 |
| Operating Cash Flow
| -184.17 | -93.838 | -54.581 | -29.779 | -36.056 | -26.844 | -28.167 | -7.231 | -6.898 | -2.213 | -1.168 | -6.225 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0.898 | -0.797 | -0.338 | -0.042 | -0.084 | -0.445 | -0.246 | -0.003 | -0.123 | -0.266 | -0.005 | -0.107 |
| Acquisitions Net
| 93.354 | 114.329 | 0.079 | 29.371 | -28.31 | 0 | 1.28 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -407.88 | -223.264 | -188.431 | -81.807 | -32.69 | -62.462 | 0 | -1 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 314.526 | 108.935 | 114.398 | 2 | 61 | 33 | 0 | 1 | 0.05 | 0 | 0 | 0 |
| Other Investing Activites
| -93.354 | -114.329 | -73.954 | -0.003 | 28.31 | -29.462 | 1.28 | 0 | 0.028 | -0.008 | 0.01 | -0.013 |
| Investing Cash Flow
| -94.252 | -115.126 | -74.292 | -50.481 | 28.226 | -29.907 | 1.034 | -0.003 | -0.095 | -0.274 | 0.006 | -0.119 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -14.486 | -0.446 | 0 | -10.293 | -2.333 | 0 | -4.667 | -0.084 | -0.076 | -0.042 | -10.522 | -0.059 |
| Common Stock Issued
| 211.184 | 291.874 | 114.242 | 25.104 | 2.283 | 44.871 | 48.565 | 16.304 | 13.095 | 6.644 | 0 | 0 |
| Common Stock Repurchased
| 0.58 | 0.183 | 0 | -0.044 | 0 | -2.955 | -1.216 | -0.173 | -0.363 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.285 | -0.72 |
| Other Financing Activities
| -12.315 | 30.633 | 11.033 | 86.588 | 0.12 | 41.916 | 8.572 | 16.207 | 0.05 | 0.795 | 12.066 | 6.585 |
| Financing Cash Flow
| 225.67 | 322.244 | 125.275 | 101.311 | 0.07 | 41.916 | 52.47 | -0.257 | 12.706 | 7.397 | 1.259 | 5.806 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -52.752 | 113.28 | -3.598 | 21.051 | -7.76 | -14.835 | 25.337 | -7.491 | 5.713 | 4.91 | 0.097 | -0.539 |
| Cash At End Of Period
| 102.827 | 155.579 | 42.299 | 45.897 | 24.846 | 32.606 | 47.441 | 3.341 | 10.832 | 5.119 | 0.209 | 0.113 |